Search

Gunaraj Dhungana Kathmandu, Nepal My name is Gunaraj Dhungana, I'm a Ph.D scholar from the central Department of Biotechnology, Tribhuvan University, Nepal. We have been working on the characterization and preparation of a phage bank to est

Phage Futures 2019 is next week! Even if you're not able to make it, we'll be posting tweets (#PhageFutures2019) and keeping you up to date on which speaker is speaking, what people's reactions are, and who's up next. Check out our Phage Fu

Mt. Sinai Hospital in NYC is now recruiting patients for a randomized, controlled, double-blind, Phase 1/2a phage therapy trial. The goal: test the safety and efficacy of Intralytix's EcoActive phage collection on intestinal AIEC (adherent

Dr. Saima Aslam and colleagues at IPATH / UCSD School of Medicine and Ampliphi Biosciences report on their use of IV phage therapy to treat biofilms associated with left ventricular assist devices (LVADs). This is now a protocol guiding cli

Phage scientists! It's time for the International Society for Viruses of Microorganisms (ISVM) elections. If you're a member, you can run for: President-elect, Vice-President, Secretary, Secretary Assistant, Treasurer, or Private Partnershi

Bacteria sometimes acquire "incorrect" CRISPR spacers in response to phage infection. Until now, no one knew whether these incorrect ("slipped") spacers had a purpose. Simon A. Jackson, Peter Fineran and co. have just shown that slipped spa

Could phages help explain the mysteriously healing qualities of India's Ganges river? If you're looking to learn about some interesting phage-related history (and mystery), you may like this excerpt of the new book "Ganges: The Many Pasts O

We are still seeking Citrobacter phages to treat a sea turtle's antibiotic-resistant shell infection. If you can help, please email staff@phage.directory! Progress so far: Good news! At least one phage active against the turtle's Citrobact

Gunaraj Dhungana Kathmandu, Nepal My name is Gunaraj Dhungana, I'm a Ph.D scholar from the central Department of Biotechnology, Tribhuvan University, Nepal. We have been working on the characterization and preparation of a phage bank to est

Our opinion piece, A Bright Outlook for Bacteriophage Applications, is featured in the Microbiome Times January 2019 edition (page 34).

Bioharmony Therapeutics and Boehringer Ingelheim just announced a collaboration to develop Acinetobacter baumannii lysin therapeutics.

CBC has provided a Canadian perspective on phage therapy (and there's a Quirks and Quarks radio show linked in the article!)

Phages for Global Health reached their 2018 fundraising goal, meaning they can deliver TWO phage workshops in 2019! Congratulations! And thanks to everyone who supports this one-of-a-kind phage nonprofit! Donate or sign up for their newslet

Jee-Hwan Oh and colleagues published a paper on how certain dietary sugars promote Lactobacillus phage production in the mouse gut.

PharmExec.com has named phage therapy as one of the top 10 drug discovery trends to watch in 2019!

Want to win one of 50 free copies of The Perfect Predator, the true story of how a global village saved the life of Tom Patterson with IV phage therapy? Sign up for the book giveaway on Goodreads.com by Jan 23. Note: you need to view it fro

Mahmuda Akter I have been working at the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) and earned my M.S. degree from the University of Dhaka in Bangladesh. I was awarded joint funding from icddr,b and SIDA to i

Silviane Miruka I am a student seeking a PhD opportunity in a phage lab. I recently did a project for my master's thesis titled "Molecular Detection of Pathogenic Staphylococcus aureus Using Phage Based Genetic Markers." Please email me at

IPATH has just received FDA approval to start its first clinical trial! This will be the first US trial involving intravenous (IV) phage treatment, and will be a collaboration with Ampliphi Biosciences.

Adaptive Phage Therapeutics has partnered with Yale University to manufacture and supply phages for use in Yale's upcoming clinical trials.